Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls

被引:40
|
作者
Constant, E. L. [1 ]
Adam, S. [2 ]
Gillain, B. [1 ]
Lambert, M. [3 ]
Masquelier, E. [4 ]
Seron, X. [5 ]
机构
[1] Catholic Univ Louvain, Dept Psychiat, B-1200 Brussels, Belgium
[2] Univ Liege, Unit Clin Psychol Ageing, Liege, Belgium
[3] Catholic Univ Louvain, Dept Internal Med, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Phys Med Unit, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Cognit Neurosci Unit, B-1348 Louvain, Belgium
关键词
Chronic fatigue syndrome; Depression; Cognition; Attention; Memory; SHORT-TERM-MEMORY; MULTIPLE-SCLEROSIS; ATTENTION;
D O I
10.1016/j.clineuro.2010.12.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object: Chronic fatigue syndrome (CFS) patients report usually cognitive complaints. They also have frequently comorbid depression that can be considered a possible explanation for their cognitive dysfunction. We evaluated the cognitive performance of patients with CFS in comparison with a control group of healthy volunteers and a group of patients with MOD. Patients and methods: Twenty-five patients with CFS, 25 patients with major depressive disorder (MDD), and 25 healthy control subjects were given standardized tests of attention, working memory, and verbal and visual episodic memory, and were also tested for effects related to lack of effort/simulation, suggestibility, and fatigue. Results: Patients with CFS had slower phasic alertness, and also had impaired working, visual and verbal episodic memory compared to controls. They were, however, no more sensitive than the other groups to suggestibility or to fatigue induced during the cognitive session. Cognitive impairments in MDD patients were strongly associated with depression and subjective fatigue; in patients with CFS, there was a weaker correlation between cognition and depression (and no correlation with fatigue). Conclusions: This study confirms the presence of an objective impairment in attention and memory in patients with CFS but with good mobilization of effort and without exaggerated suggestibility. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 50 条
  • [41] Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder
    Ziegelmayer, Christoph
    Hajak, Goran
    Bauer, Anne
    Held, Marion
    Rupprecht, Rainer
    Trapp, Wolfgang
    JOURNAL OF ECT, 2017, 33 (02) : 104 - 110
  • [42] Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls
    Groven, Nina
    Reitan, Solveig Klaebo
    Fors, Egil Andreas
    Guzey, Ismail Cuneyt
    PSYCHONEUROENDOCRINOLOGY, 2021, 131
  • [43] URINARY NEOPTERINE LEVELS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: ALTERATIONS AFTER TREATMENT WITH PAROXETINE AND COMPARISON WITH HEALTHY CONTROLS
    Taymur, Ibrahim
    Ozdel, Kadir
    Ozen, Nurper Erberk
    Gungor, Buket Belkiz
    Atmaca, Murad
    PSYCHIATRIA DANUBINA, 2015, 27 (01) : 25 - 30
  • [44] Stress effects on cognitive function in patients with major depressive disorder: Does childhood trauma play a role?
    Kuehl, Linn K.
    Schultebraucks, Katharina
    Deuter, Christian E.
    May, Anita
    Spitzer, Carsten
    Otte, Christian
    Wingenfeld, Katja
    DEVELOPMENT AND PSYCHOPATHOLOGY, 2020, 32 (03) : 1007 - 1016
  • [45] The role of depression in cognitive inpairment in patients with chronic fatigue syndrome
    Santamarina-Perez, Filar
    Freniche, Veronica
    Jose Eiroa-Orosa, Francisco
    Llobet, Guillem
    Saez, Naia
    Alegre, Jose
    Jacas, Carlos
    MEDICINA CLINICA, 2011, 136 (06): : 239 - 243
  • [46] Oxidative Stress and Antioxidant Parameters in Patients With Major Depressive Disorder Compared to Healthy Controls Before and After Antidepressant Treatment: Results From a Meta-Analysis
    Jimenez-Fernandez, Sara
    Gurpegui, Manuel
    Diaz-Atienza, Francisco
    Perez-Costillas, Luca
    Gerstenberg, Miriam
    Correll, Christoph U.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (12) : 1658 - +
  • [47] Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression
    Robertson, MJ
    Schacterle, RS
    Mackin, GA
    Wilson, SN
    Bloomingdale, KL
    Ritz, J
    Komaroff, AL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (02) : 326 - 332
  • [48] Major Depressive Disorder in recovery and neuropsychological functioning: Effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery
    Herrera-Guzman, Ixchel
    Gudayol-Ferre, Esteve
    Herrera-Abarca, Jorge E.
    Herrera-Guzman, Daniel
    Montelongo-Pedraza, Pedro
    Padros Blazquez, Ferran
    Pero-Cebollero, Maribel
    Guardia-Olmos, Joan
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 123 (1-3) : 341 - 350
  • [49] Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder
    Candido, CL
    Romney, DM
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 70 (03) : 261 - 271
  • [50] Effects of cortisol on hippocampal subfields volumes and memory performance in healthy control subjects and patients with major depressive disorder
    Travis, Scott G.
    Coupland, Nicholas J.
    Hegadoren, K.
    Silverstone, Peter H.
    Huang, Yushan
    Carter, Rawle
    Fujiwara, Esther
    Seres, Peter
    Malykhin, Nikolai V.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 201 : 34 - 41